Evaluation of 2 Doses of Intravenous Droperidol in the Prevention of Postoperative Nausea

2014-07-23 21:30:01 | BioPortfolio


In this prospective, randomised, placebo-controlled study, the researchers determined whether 0.625 mg or 2.5 mg of IV droperidol given 30 min before emergence from general anaesthesia reduces the incidence of immediate and delayed post operative nausea and vomiting (PONV) in thyroid surgical female population. Two hundred and forty six female patients receiving general anaesthesia for thyroid surgery received either droperidol 0.625 mg or droperidol 2.5 mg or placebo before emergence.


- Principal Objective : Our study examined one main question: Are there difference in efficacy between droperidol IV 0.625 mg or 2.5 mg for the treatment or prophylaxis of PONV to surgical patient undergoing thyroid surgery when they receive it 30 min before emergence from general anaesthesia?

- Secondary Objective :

- comparison of the % of patients in every group:

- having a complete control of their nausea

- requiring secondarily the appeal to another anti-emetic treatment in postoperative

- presenting an Adverse event

- Compare score of sedation in ach groups

- Evaluate electrocardiograph

- Compare the morphine consumption

- Study design : Prospective, randomized, monocenter, double-blind study

- Inclusion criteria :

- Female

- More than 18 years old

- Patients scheduled for thyroid surgery

- Simplified Apfel score ≥ 2

- ASA score : 1-2

- Informed consent obtained from the patient

- the women in age of procreate must have a reliable contraceptive method

- Exclusion criteria :

- age < 18 years old

- male

- obesity

- present a severe depressive syndrome

- pregnancy women

- trouble of cardiac rate

- alcoholism

- contra-indication for Droperidol prescription

- Study plan: three parallel groups will receive 2 different doses of Droperidol or placebo at the end of surgery.

- Group 1: 0,625mg of Droperidol at the end of surgery

- Group 2: 2,5mg of Droperidol at the end of surgery

- Group 3: Placebo at the end of surgery

- Number of subjects : 246

Study Design

Allocation: Randomized, Control: Dose Comparison, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Prevention






Département d'Anesthésie-Réanimation II ; Groupe Hospitalier Sud, CHU de Bordeaux




University Hospital, Bordeaux

Results (where available)

View Results


Published on BioPortfolio: 2014-07-23T21:30:01-0400

Clinical Trials [292 Associated Clinical Trials listed on BioPortfolio]

Role of Droperidol in Postoperative Vomiting

Protocol title: Role of low dose droperidol in postoperative vomiting Purpose: Evaluate the efficacy of droperidol to postoperative nausea and vomiting when administrated at the introduct...

The Effects of the Anti Nausea Drugs Droperidol and Ondansetron on the Way the Heart Recovers Between Beats

We are investigating a new technique for testing the effect of drugs on electrical activity in the heart. Disturbances of this electrical activity can cause life-threatening changes to hea...

Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis

The purpose of this study is to determine how automated recommendations are best presented to optimize the adherence to guidelines on prophylaxis for nausea and vomiting after surgery.

Nausea and Vomiting After Gynecologic Surgery

In this cross-section study, all patients in the gynecologic ward of Peking Union Medical College Hospital will accepted a survey about the prevalence and severity of nausea and vomiting a...

Treatment Algorithm for Nausea and Vomiting in the Palliative Phase

Nausea and vomiting are frequently occurring problems in the palliative phase of patients with cancer. Between 20-50% of them regularly suffer from nausea, retching or vomiting. Often the ...

PubMed Articles [181 Associated PubMed Articles listed on BioPortfolio]

Randomized placebo-controlled trial of droperidol and ondansetron for adult emergency department patients with nausea.

To separately compare effectiveness of intravenous (IV) droperidol 1.25 mg and ondansetron 8 mg IV with 0.9% saline placebo for adult emergency department (ED) patients with nausea. A novel primary ou...

Functional brain networks and neuroanatomy underpinning nausea severity can predict nausea susceptibility using machine learning.

Nausea is an adverse experience characterised by alterations in autonomic and cerebral function. Susceptibility to nausea is difficult to predict, but machine learning has yet to be applied to this fi...

The Management of Nausea at the End of Life.

The evaluation and management of nausea in patients near the end of life can be more challenging than that of nausea in patients undergoing antineoplastic therapies. Unlike in the oncology setting in ...

Effect of acupressure application to the P6 acupoint before laparoscopic cholecystectomy on postoperative nausea-vomiting: A randomized controlled clinical study.

Nausea and vomiting are common postoperative complications that occur within the first 24 h in adults. Clinical practice guidelines and a Cochrane review recommend stimulating the P6 acupoint to pre...

Chronic Atypical Antipsychotic Use Is Associated With Reduced Need for Postoperative Nausea and Vomiting Rescue in the Postanesthesia Care Unit: A Propensity-Matched Retrospective Observational Study.

Atypical antipsychotics are efficacious for chemoprophylaxis against chemotherapy-induced nausea and vomiting, but perioperative investigations have been scant. We sought to examine the association be...

Medical and Biotech [MESH] Definitions

A drug combination that contains DIPHENHYDRAMINE and THEOPHYLLINE. It is used for treating vertigo, motion sickness, and nausea associated with pregnancy. It is not effective in the treatment of nausea associated with cancer chemotherapy.

A narcotic analgesic partly metabolized to meperidine in the liver. It is similar to morphine in action and used for neuroleptanalgesia, usually with droperidol.

A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in conjunction with an opioid analgesic such as FENTANYL to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon. It is also used as a premedicant, as an antiemetic, and for the control of agitation in acute psychoses. (From Martindale, The Extra Pharmacopoeia, 29th ed, p593)

Emesis and queasiness occurring after anesthesia.

A histamine H1 antagonist used in the treatment of motion sickness, vertigo, and nausea during pregnancy and radiation sickness.

More From BioPortfolio on "Evaluation of 2 Doses of Intravenous Droperidol in the Prevention of Postoperative Nausea"

Quick Search


Relevant Topics

Thyroid Disorders
The thyroid is a butterfly-shaped gland in the neck, just above thecollarbone and is an endocrine gland that make hormones. These Thyroid hormones control the rate of many activities in the body, including how fast the body burns calories and how fast th...

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...

Searches Linking to this Trial